News

Shockwave Medical, Inc., a trailblazer in advancing and bringing to market groundbreaking technologies for treating cardiovascular ailments, has announced the appointment of Renee Gaeta as its new Chief Financial Officer (CFO), effective February 5, 2024. Renee takes over from Dan Puckett, who has served as Shockwave’s CFO since 2016 and has announced his retirement.

“Renee is a highly skilled and accomplished executive with a proven track record in the medical device and healthcare industries,” said Doug Godshall, Chief Executive Officer at Shockwave. “I am thrilled to welcome Renee to Shockwave and look forward to partnering with her through our next phase of growth and profitability. I would also like to thank Dan Puckett for his exemplary leadership and outsized contribution to the success of Shockwave. Though Dan will be missed, fortunately he will continue to work with us in a consulting capacity.”

Renee Gaeta most recently held the position of CFO at Eko Health, overseeing both finance and human resources as the company expanded its digital cardiopulmonary care platform. She has also been a board member and part of the audit committee at Candel Therapeutics since August 2022. Prior to her role at Eko Health, Renee served as CFO and a member of the executive team at Establishment Labs Holdings, Inc., contributing significantly to the company’s successful initial public offering and global business growth. Renee earned her Bachelor of Science degree in accounting with honors from Loyola Marymount University and holds a Certified Public Accountant license in the State of California.

“Shockwave is one of the most exciting and innovative companies in the medical technology industry and it is an honor to be joining the company at such a pivotal time in its growth,” said Renee. “The progress Shockwave has made in establishing IVL as a standard of care while also strategically expanding the business to help patients is inspiring. I am thrilled to be part of the team and the mission to transform treatment paradigms for poorly served patient populations with breakthrough technologies.”

© Shockwave Medical Inc.